Eli Lilly CEO on Submitting COVID-19 Antibody Drug to FDA
Bloomberg Economics Senior U.S. Economist Yelena Shulyatyeva and Bloomberg Stocks Editor Dave Wilson discuss the latest FOMC minutes. Former Republican Strategist and Bloomberg Contributor Rick Davis provides a preview of the Vice Presidential debate. David Ricks, CEO at Eli Lilly, talks about submitting a COVID-19 antibody for FDA emergency approval. Bloomberg News Health Reporter Michelle Cortez shares a coronavirus and vaccine update. And we Drive to the Close with Rich Weiss, CIO of Multi-Asset Strategies at American Century Investments. Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.